...
Predicted Opening Price for Zomedica Pharmaceuticals Corp of Friday, May 13, 2022.
| Fair opening price May 13, 2022 | Current price |
|---|---|
| $0.20 | $0.20 (Overvalued) |
What's happening with Zom stock?
Dec 02, 2021 · Instead, ZOM is traded on the NYSEAmerican, which deals primarily in small-cap stocks and derivatives. As such, ZOM is seen as more of a ‘penny stock’ by most analysts on Wall Street. Looking at our technical analysis, we see that ZOM experienced significant volatility between February and April 2021.
Will zomedica stock fall more before it goes up again?
Apr 24, 2022 · Zomedica's stock was trading at $0.2078 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ZOM shares have increased by 15.5% and is now trading at $0.24. View which stocks have been most impacted by COVID-19.
Will Zom price go up or down in 14 days?
ZOM : Long term Zomedica stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year) Forecast for 2022 May. is $.33 , for 2023 Apr. is $.38 , for 2026 Apr. is $.50 , for 2027 Apr. is $.31 , for 2031 Apr. is $.25 , and for 2032 Apr. is $.61.
Is Zom a buy or sell in 2020?
Apr 14, 2021 · ZOM’s market capitalization has fallen below $1 billion now amid the crash in its stock price. It's worth noting that while the stock has fallen sharply from the peaks, it's still up ...
Is ZOM expected to go up?
Will Zomedica go up tomorrow?
...
Munafa value: 25 as on 10 Tue May 2022.
| Downside target | 0.18 |
|---|---|
| Upside target | 0.22 |
| Upside target | 0.23 |
| Upside target | 0.24 |
Is ZOM a good stock to buy right now?
Why did Zomedica stock go up today?
Will ZOM recover?
Why is Zomedica stock dropping?
Is Zomedica a good long term investment?
What is Nio price target?
The 28 analysts offering 12-month price forecasts for NIO Inc have a median target of 30.94, with a high estimate of 82.16 and a low estimate of 22.86.
Is Zomedica undervalued?
What is happening to Zomedica?
How many shares of ZOM are there?
| Avg Vol (3 month) 3 | 18.43M |
|---|---|
| Shares Outstanding 5 | 979.9M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 965.89M |
| % Held by Insiders 1 | 2.56% |
What is ZOM?
Zomedica Pharmaceuticals is a veterinary health company that produces point-of-care diagnostic devices for veterinarians. Zomedica has just begun s...
Is ZOM a good investment opportunity?
As a small-cap stock, ZOM is an excellent investment if you are looking for huge gains. However, as you can imagine, small-cap stocks are much risk...
Where can I buy ZOM stock?
We recommend using eToro if you are looking to buy Zomedica stock. eToro offers 0% commission trading and fractional investing, making the platform...
Will the price of ZOM go up in the future?
If Zomedica can begin showing some solid revenue growth, it’s highly likely that the stock will increase. Although it may be more of a long-term pl...
Is buying ZOM risky?
As noted, due to ZOM being a small-cap stock, it is much riskier than buying an established stock. However, this provides the opportunity for more...
How has Zomedica's stock been impacted by COVID-19 (Coronavirus)?
Zomedica's stock was trading at $0.2078 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organ...
When is Zomedica's next earnings date?
Zomedica is scheduled to release its next quarterly earnings announcement on Tuesday, May 10th 2022. View our earnings forecast for Zomedica .
How were Zomedica's earnings last quarter?
Zomedica Corp. (NYSEAMERICAN:ZOM) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per shar...
What guidance has Zomedica issued on next quarter's earnings?
Zomedica issued an update on its FY 2021 earnings guidance on Monday, March, 14th. The company provided earnings per share (EPS) guidance of for th...
Who are Zomedica's key executives?
Zomedica's management team includes the following people: Mr. Robert Cohen , CEO & Director (Age 63, Pay $412.79k) Ms. Ann Marie Cotter CPA , C...
Who are some of Zomedica's key competitors?
Some companies that are related to Zomedica include Protagonist Therapeutics (PTGX) , Keros Therapeutics (KROS) , Myovant Sciences (MYOV) , Axs...
What is Zomedica's stock symbol?
Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ZOM."
Who are Zomedica's major shareholders?
Zomedica's stock is owned by a variety of retail and institutional investors. Top institutional investors include State Street Corp (2.93%), BlackR...
Which institutional investors are selling Zomedica stock?
ZOM stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Commonwealt...
Is Zomedica a buy right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zomedica in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Zomedica stock.#N#View analyst ratings for Zomedica or view top-rated stocks.
What stocks does MarketBeat like better than Zomedica?
Wall Street analysts have given Zomedica a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Zomedica wasn't one of them.
When is Zomedica's next earnings date?
Zomedica is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.#N#View our earnings forecast for Zomedica.
How were Zomedica's earnings last quarter?
Zomedica Corp. (NYSEAMERICAN:ZOM) released its earnings results on Thursday, November, 12th. The company reported ($0.01) EPS for the quarter.#N#View Zomedica's earnings history.
How has Zomedica's stock been impacted by Coronavirus (COVID-19)?
Zomedica's stock was trading at $0.2078 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ZOM stock has increased by 188.8% and is now trading at $0.6002.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for ZOM?
1 analysts have issued 12-month price objectives for Zomedica's shares. Their forecasts range from $0.30 to $0.30. On average, they anticipate Zomedica's share price to reach $0.30 in the next year.
Who are some of Zomedica's key competitors?
Some companies that are related to Zomedica include Protagonist Therapeutics (PTGX), Ligand Pharmaceuticals (LGND), Morphic (MORF), Rocket Pharmaceuticals (RCKT), IGM Biosciences (IGMS), Aurinia Pharmaceuticals (AUPH), Nuvation Bio (NUVB), Organogenesis (ORGO), Amarin (AMRN), Centessa Pharmaceuticals (CNTA), Ironwood Pharmaceuticals (IRWD), Harmony Biosciences (HRMY), Dynavax Technologies (DVAX), MorphoSys (MOR) and Indivior (INVVY).#N#View all of ZOM's competitors..
Long term Zomedica (ZOM) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)
Forecast for 2021 Oct. is $.59 , for 2022 Sep. is $.54 , for 2025 Sep. is $.97 , for 2026 Sep. is $1.10 , for 2030 Sep. is $1.20 , and for 2031 Sep. is $1.14.
Frequently Asked Questions about Zomedica stock forecast
From Zomedica stock forecast , Zomedica (ZOM) stock cannot be a good investment choice. According to AI Pickup, the Zomedica stock price forecast for 2021 Oct. is $0.594011410091017
Is Zom stock a good investment?
ZOM stock is a good long-term investment. ZOM looks like a good long-term investment. In its filing, citing data from MarketsandMarkets, ZOM said that the market opportunity for companion animal diagnostics is expected to rise from $1.7 billion in 2019 to $2.8 billion in 2024. Article continues below advertisement.
How much will Zomedica make in 2022?
From a valuation perspective, analysts expect Zomedica to post revenues of $15.21 million in 2022, which would mean a 2022 price-to-sales multiple of over 62x. That said, ZOM shouldn't be valued on near-term earnings but long-term potential as its revenues would increase significantly after Truforma has commercial success.
Can short squeezes trigger short term price movement?
Usually, short squeezes can only trigger a short-term price movement. However, as we’ve seen this year, the short squeeze can also have a medium to long-term impact. Many of the companies that were pumped by WallStreetBets capitalized on the rise in their stocks to issue more shares. ZOM also issued more shares, ...
What is Truforma used for?
Truforma is a point-of-care device meant to be used by veterinary doctors. The platform would help detect thyroid and adrenal diseases in pets. Add the projected growth in pet care in the U.S. and we had a fundamental story around Zomedica. Article continues below advertisement.
ZOM Target Price
ZOM price target in 14 days: 108.326 USD* upside and 108.326 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Zom ( ZOM ) Cryptocurrency Market info
Recommendations: Buy or sell ZOM? Cryptocurrency Market & Coin Exchange report, prediction for the future: You'll find the ZOM Price prediction below. According to present data ZOM ( ZOM) and potentially its market environment has been in a bullish cycle in the last 12 months (if exists).
ZOM ( ZOM ) Price Prediction, Forecast for next months and years
Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026.
ZOM price predictions by tech sector
Wanted to know how the future cryptocurrency prices would grow if we used the price gains of the leading social/technological innovations like Facebook, Smartphones, Data, etc.? Our forecasts here could give you some pointers on the potential future of these innovative technologies.
How much cash does Zomedica have in 2021?
Liquidity and Outstanding Share Capital Zomedica had cash and cash equivalents of approximately $276.6 million as of March 31, 2021, compared to approximately $1.5 million as of March 31, 2020.
Who is leaving Zomedica?
Separately, the Company announced that Dr. Stephanie Morley will be leaving Zomedica. “As part of the original founding team who created the vision of Zomedica, Dr. Morley’s accomplishments on behalf of the Company are numerous and significant.
How much cash is used in operating activities for 2021?
Net cash used in operating activities for the three months ended March 31, 2021 was approximately $2.6 million, compared to approximately $2.2 million for the three months ended March 31, 2020, an increase of approximately $0.4 million, or 21%.
How much is research and development expense for 2021?
Research and development expense for the three months ended March 31, 2021 was approximately $0.4 million compared to approximately $0.6 million for the three months ended March 31, 2020, a decrease of approximately $0.2 million, or 34%.
Where is Zomedica located?
About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians.
How much is General and Administrative expense for 2020?
General and administrative expense for the year ended December 31, 2020 was approximately $6.0 million, compared to approximately $7.0 million for the year ended December 31, 2019, a decrease of approximately $1.0 million or 15%.
What is forward-looking information?
Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results.
